High Court Ruling May Hobble Suits Against Generics

Law360, New York (June 23, 2011, 1:05 PM EDT) -- The U.S. Supreme Court's ruling Thursday that federal law preempts state failure-to-warn claims against generic-drug manufacturers will severely hinder or even wipe out product liability suits against generics companies, lawyers said.

In a 5-4 reversal, the Supreme Court ruled that state-law tort claims against generics manufacturers were preempted because the Hatch-Waxman Amendments require generics to use the same warning label as brand-name companies.

The opinion reverses Fifth and Eighth Circuit decisions that allowed state-law tort claims against Pliva Inc. and Activis Inc., in consolidated suits claiming...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.